Track record

Assignments, results and recommendations

The substance that allows restraint.

Results

Selected results

These figures come from assignments in corporate, mid-market and owner-managed businesses. I attribute them to specific companies in conversation.

  1. +52 %

    Turnaround of a specialty pharma business

    Revenue growth following the realignment of segmentation, territory structure and sales steering.

  2. +26 %

    Growth after restructuring

    Result in the following year, achieved with a field force reduced by roughly 40 per cent.

  3. +22.4 %

    Regional contribution

    Growth at an 18.8 per cent lower headcount, in a corporate setting with P&L accountability.

  4. +19.4 %

    National sales

    Growth across all brands, 89.3 per cent on promoted brands. Team of 130, 12 direct reports, €120m revenue.

  5. €130m

    Largest P&L held

    Full accountability for a unit of this scale, including forecasting and resource allocation.

Commercial pharma

Companies and assignments

01APONTIS PHARMA AG
02Galderma Laboratorium GmbH
03Otsuka Pharma GmbH
04ITM Isotope Technologies Munich SE
05B2B Medical GmbH
06Leti Pharma GmbH
07Müller Medien GmbH & Co. KG
08Hecht Pharma GmbH (Gall Pharma Gruppe)
09Bios Medical Services GmbH
10ProStrakan Pharma GmbH (Kyowa Kirin GmbH)
11Novartis Pharma GmbH
12Orthomol GmbH
13MiP-Holding
14AstraZeneca GmbH
Recommendations

What others say about working together

01 / 13
I had the pleasure of working alongside Joerg Schmitz when we were both Business Unit Heads for Rx, Joerg in Germany and I in the Nordics. Even though we were based in different markets, our roles often intersected through our regional network in EMEAC, where Joerg quickly became a highly respected and valued colleague. What truly stood
Ulf Anderson
Ulf Anderson
Nordic General Management & Transformation Leader
Zusammenarbeit über Teamgrenzen hinweg · April 2025
Joerg and I worked together as EMEAC business unit heads in the dermatology space. He was a trusted colleague who I could always rely upon to provide solid strategic thinking, an ability to simplify complex situations, and adapt to any situation. As an executive leader, he was looked upon as an expert in go to market strategy, brand
Anant Parikh
Anant Parikh
Biopharmaceutical Executive
Zusammenarbeit im selben Team · Februar 2025
It was a true pleasure to work closely with Jörg Schmitz on various aspects of Apontis Pharma's transformation in 2023/2024. Jörg was a crucial member of a small task team asked to reinvent the operations of the entire company. While he focused on building a strong salesforce team and on designing an efficient sales strategy, I had
José Airas
José Airas
Pharma & Biotech leader bridging R&D and Commercial Ops. I specialize in modernizing GTM
Zusammenarbeit im selben Team · Januar 2025
Worked together with Joerg and had an excellent team work on the management team!
Dr. Oliver P. Kühn, PhD
Dr. Oliver P. Kühn, PhD
Member of the board of directors / Unabhängiger Verwaltungsrat
Zusammenarbeit im selben Team · Januar 2025
I have worked closely with Joerg when I was a Regional Business Unit Lead at Galderma and Joerg was leading the Business Unit in Germany. While working together on business opportunities and challenges for the region and Germany, Joerg clearly demonstrated his leadership skills, ability to set up a vision for his business, creativity, as
Jean-François Mocho
Jean-François Mocho
VP, General Manager France
War direkte Führungskraft von Joerg Schmitz · Januar 2025
I had the chance to work with Joerg at Otsuka. We were both Nephrology Business Unit head in our respective countries (France and Germany). Among this European community of BU heads, Joerg’s vision and understanding of the market, as well as his strategic thinking and solution oriented approach have been of high value to the group. It
Anne Creuzé
Anne Creuzé
Managing Director chez Otsuka Pharmaceutical France
Zusammenarbeit über Unternehmensgrenzen hinweg · Januar 2025
As CEO of Apontis Pharma, I had the privilege of hiring Jörg Schmitz as interim Head of Sales in October 2023. At that time, we faced the challenge of restoring profitability after losses in 2023. Realigning the sales force was crucial, and Jörg played a key role. Jörg brought extensive experience in sales leadership and immediately
Bruno E. Wohlschlegel
Bruno E. Wohlschlegel
Board Member & Strategic Advisor
War direkte Führungskraft von Joerg Schmitz · Januar 2025
Ich hatte das Vergnügen, mit Joerg bei APONTIS PHARMA zusammenzuarbeiten, und kann mit voller Überzeugung sagen, dass er eine herausragende Führungskraft ist. Besonders hervorzuheben ist Joergs außergewöhnliche Kommunikationsfähigkeit und die aufrichtige Wertschätzung gegenüber den Mitarbeitern. Diese Eigenschaften haben zu einer
Yvonne Gehlen
Yvonne Gehlen
Vertriebsleitung Pneumologie/ Regionale Vertriebsleitung API
Berichtete direkt an Joerg Schmitz · Dezember 2024
Sehr gerne empfehle ich als CPO der APONTIS PHARMA Jörg Schmitz aufgrund: - einem sehr guten, vorhandenem Netzwerk im Vertriebs-Bereich der Pharma-Branche, - einer schnellen und effektiven Vertriebsstruktur-Planung und -Implementierung, - einer sehr guten Expertise in den Tools der Vertriebssteuerung und der Incentivierung des Vertriebs,
Thomas Milz
Thomas Milz
Managing Director APONTIS PHARMA Deutschland GmbH&Co. KG
Vorgesetzte Ebene, ohne direkte Führung · September 2024
I had the pleasure of working with Joerg at ProStrakan, where he excelled in sales, business management, and implementing effective structures. His strategic thinking, leadership, and ability to drive innovation consistently delivered results. Joerg brings clarity and efficiency to complex projects and fosters strong collaboration within
Shannon Brown III
Shannon Brown III
International Healthcare Executive
Berichtete direkt an Joerg Schmitz · September 2024
Jörg Schmitz ist ein sehr erfahrener und nachweislich erfolgreicher Manager im Pharma-Business. Sowohl als Sales Director, Commercial Head als auch darüber hinaus hat Jörg die Fähigkeit, komplexe Situationen schnell und umfassend zu analysieren und passende Wachstumschancen zu identifizieren. Dies gelingt ihm sowohl in kritischen,
Marcus Haupenthal
Marcus Haupenthal
We rise by lifting others
Berichtete direkt an Joerg Schmitz · September 2024
I had the privilege of working closely with Joerg during his time as Business Unit Head RX for GER & AT at Galderma, and I can confidently say that he is a highly skilled and effective leader in the pharmaceutical industry. What sets Joerg apart is his ability to implement structure and drive performance. He developed Sales Force
Riccardo De Giusti
Riccardo De Giusti
General Manager Southern Europe
Zusammenarbeit im selben Team · September 2024
Jörg is a dynamic and highly effective sales manager who always leads by example. Have greatly enjoyed working together with him.
Paul Sampson
Paul Sampson
Managing Director at Sampson Europe
Joerg Schmitz war Kunde · August 2009

All recommendations in full on LinkedIn.

Accredited partner

Interim service providers, networks and associations

Bridge imp GmbH
Deutsche Interim AG
ATREUS, A Heidrick & Struggles Company
Ludwig Heuse GmbH
Healthcare Shapers